Summary:

Click image to enlargeThe migraine study is a clinical research study to evaluate Rimegepant in Migraine Prevention.
Qualified Participants Must:
Be at least 18 years old
Have at least 4- 18 moderate or severe migraines per month
Qualified Participants May Receive:
All study related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related time and travel may be available.